Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kamada Ltd. - Ordinary Shares (NQ:KMDA)

8.635 -0.085 (-0.97%)
Streaming Delayed Price Updated: 2:24 PM EDT, Sep 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kamada Ltd. - Ordinary Shares

< Previous 1 2 3 Next >
News headline image
Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth ↗
Kamada (NASDAQ:KMDA) outlined its growth strategy, product portfolio and financial outlook during a company presentation, emphasizing demand for specialty plasma-derived therapies and a plan to expand... 
Via MarketBeat
News headline image
Kamada (KMDA) Q2 2026 Earnings Call Transcript ↗
KEDRAB sales and distribution expansion drive record revenue and EBITDA growth. 
Via The Motley Fool
Topics Earnings
News headline image
Kamada Q2 Earnings Call Highlights ↗
Kamada (NASDAQ:KMDA) reported record revenue and adjusted EBITDA for the second quarter and first half of 2026, driven by higher sales of its specialty plasma-derived products, including KEDRAB,... 
Via MarketBeat
Topics Earnings
Kamada Ltd (NASDAQ:KMDA) Reports Record 2025 Results Despite Q4 Earnings Miss ↗
Via Chartmill
News headline image
Earnings Scheduled For November 10, 2025 ↗
 
Via Benzinga
News headline image
An Overview of Kamada's Earnings ↗
 
Via Benzinga
News headline image
An Overview of Kamada's Earnings ↗
 
Via Benzinga
News headline image
Kamada (KMDA) Q1 2026 Earnings Transcript ↗
Kamada (KMDA) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Kamada Q1 Earnings Call Highlights ↗
Kamada (NASDAQ:KMDA) reiterated its full-year 2026 outlook after reporting first-quarter results that management said were in line with expectations, excluding a temporary shipment delay that shifted... 
Via MarketBeat
Topics Earnings
News headline image
Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio
Via TheNewswire.com
News headline image
Earnings Preview For Kamada ↗
 
Via Benzinga
News headline image
Kamada Reports Strongest Quarter For The Year In Q3, With Over 30% Profitability Increase Year-Over-Year
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Kamada Reports Strongest Quarter For The Year In Q3, With Over 30% Profitability Increase Year-Over-Year
Via TheNewswire.com
News headline image
Kamada (KMDA) Q3 2025 Earnings Call Transcript ↗
Kamada (KMDA) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
KAMADA LTD (NASDAQ:KMDA) Reports Mixed Q3 2025 Results with Revenue Beat and Pre-Market Surge ↗
Kamada (KMDA) Q3 2025 earnings show revenue beat estimates, driving a positive market reaction. The company reported strong year-over-year growth in sales and profitability. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
KAMADA LTD (NASDAQ:KMDA) Reports Mixed Q2 2025 Earnings with Strong EPS Beat and Raised Profitability Guidance ↗
Kamada Ltd (KMDA) reported mixed Q2 2025 earnings, with revenue slightly below estimates but EPS beating forecasts. Stock rose pre-market as profitability outlook improved. 
Via Chartmill
News headline image
Kamada Q1 Results: Double-Digit Growth, Company Reiterates Guidance As It Hits Multiple Milestones Including Plasma Business Expansion
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Kamada Q1 Results: Double-Digit Growth, Company Reiterates Guidance As It Hits Multiple Milestones Including Plasma Business Expansion
Via TheNewswire.com
News headline image
Earnings Scheduled For August 13, 2025 ↗
 
Via Benzinga
News headline image
Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM
Via TheNewswire.com
News headline image
Kamada Expects Third Plasma Collection Site To Support Its Hyper-Immune Plasma Needs And Add Up To $10M In Annual Revenue At Full Capacity
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Earnings Scheduled For May 14, 2025 ↗
 
Via Benzinga
News headline image
Kamada Expects Third Plasma Collection Site To Support Its Hyper-Immune Plasma Needs And Add Up To $10M In Annual Revenue At Full Capacity
By Meg Flippin Benzinga 
Via TheNewswire.com
News headline image
Kamada Is Bringing Relief To Those With Rare And Serious Conditions
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Kamada Is Bringing Relief To Those With Rare And Serious Conditions
Via TheNewswire.com
News headline image
Sidoti Events, LLC's Virtual March Small-Cap Conference
Via ACCESS Newswire
News headline image
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.